Thursday, 14 February 2019

Reuters Health Report: Merck to further study Keytruda in prostate cancer after early success

Reuters.com Newsletter

Merck to further study Keytruda in prostate cancer after early success

Merck & Co Inc said on Thursday it was launching three late-stage studies for its cancer immunotherapy Keytruda as a combination treatment for prostate cancer after the drug showed anti-tumor activity in an early-stage trial.

Precious antibiotics still being used to boost animal growth: OIE

Farmers in 45 countries still use antibiotics to boost animal growth, despite warnings from health experts and bans on the practice in many parts of the world, the World Organization for Animal Health (OIE) said on Thursday.

Singapore police say American accused of leaking HIV data 'pathological liar'

Singapore police said on Wednesday a U.S. citizen accused of leaking the names of more than 14,000 HIV-positive people was "a pathological liar", in a case that has raised concern over data privacy in the city-state.

Turkey's pharmacists struggling to obtain medicines: association

Turkey's pharmacists are struggling to obtain medicines as suppliers wait for the implementation of a new euro-to-lira exchange rate used in setting drug prices, the Turkish Pharmacists' Association said on Thursday.

Aggressive sanitizing at home lowers post-hospital MRSA risk

(Reuters Health) - A six-month program of aggressively washing and sanitizing at home after surgery can lower the risk of developing a potentially-deadly infection for people who harbor the antibiotic-resistant bacterium known as MRSA, a new study suggests.

Heart attack tied to edible marijuana is a warning to doctors

(Reuters Health) - As medical and recreational marijuana becomes legal in more and more places, experts worry there isn't enough science on the risks and benefits of the drug, especially for patients with heart disease.

Certain drugs, supplements may improve sperm health

(Reuters Health) - Men with infertility may have better-quality sperm when they take certain nutritional supplements and medicines, but there's little evidence about whether that leads to pregnancies and births, a research review concludes.

Clinigen agrees to buy U.S. rights to Novartis' cancer drug Proleukin

British pharmaceutical firm Clinigen Group Plc said on Wednesday it had agreed to acquire the U.S. rights to Swiss drugmaker Novartis AG's skin and lung cancer drug Proleukin for a total of $210 million, including some future payments.

Teva CEO: 'Content' with 2/3 access of payers for migraine drug Ajovy

Teva Pharmaceutical Industries is "content" with having its new migraine drug Ajovy covered by nearly two-thirds of payers in the United States, Chief Executive Kare Schultz told Reuters on Wednesday.

Brazil's BRF recalls chicken export products over salmonella fears

Brazilian food processor BRF SA recalled almost 500 tonnes of fresh chicken products on Wednesday due to salmonella contamination worries, in a move affecting several key export markets in Asia, Africa and the Middle East.

Teen cannabis use linked to higher risk of adolescent depression

Teenagers who use cannabis have a higher risk of developing depression and suicidal thoughts as young adults and should be made aware of those risks by parents and doctors, scientists said on Wednesday.

Related Videos

Rap scores a breakthrough at the Grammy awards

INSIGHT: A look back at the Grammy Awards

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS